Лансурф
(трифлуридин: 20 мг, типірацил: 8,19 мг)
(20/8.19)
(28)
(Таб)
Lonsurf (trifluridine20 mg/ tipiracil 18,9 mg) NATCO, India
In Stock
Colorectal cancer Lansurf is indicated as monotherapy for adult patients with metastatic colorectal cancer who have previously undergone treatment, but which are not indicated for established types of therapy, including fluoride-based chemotherapy midina, oxaliplatin and irinotecan, as well as anti-VEGF and anti-EGFR agents Lansurf is indicated as monotherapy for adult patients with metastatic vulcan cancer, including patients with adenocarcinoma. gastroesophageal transition, which had previously undergone at least two modes of systemic therapy, with progressive illness.
-
Commercial name:Лансурф
-
Сhemical name:трифлуридин: 20 мг, типірацил: 8,19 мг
-
Dosage:20/8.19
-
Quantity:28
-
Release form:Таб
-
Производитель:Natco, Индия
No reviews yet